Cover Image
市場調查報告書

美國的內部/外部照射療法設備市場分析

US Market Report for Internal and External Radiation Therapy Devices - MedCore

出版商 iData Research Inc. 商品編碼 360605
出版日期 內容資訊 英文 138 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的內部/外部照射療法設備市場分析 US Market Report for Internal and External Radiation Therapy Devices - MedCore
出版日期: 2016年02月01日 內容資訊: 英文 138 Pages
簡介

本報告提供美國的內部照射療法 (近距離放射治療) 及外部照射療法 (體外放射治療) 用醫療設備的市場相關分析,各類別的市場規模的變化及預測 (過去4年、今後7年份) ,及各產品的詳細趨勢調查、估計,整體市場結構,主要的推動及阻礙市場要素,近幾年的企業間競爭情勢的資訊彙整,為您概述為以下內容。

摘要整理

分析方法

  • 分析範圍
  • IDATA的9階段的分析方法

癌症的發病率

  • 簡介
  • 癌症的各種類的趨勢
    • 性器官癌症
    • 消化器官癌症
    • 呼吸系統癌症
    • 乳癌
    • 尿道癌症
    • 皮膚癌症
    • 淋巴瘤
    • 內分泌系癌症
    • 白血病
    • 口腔癌症/咽癌症
    • 骨髓瘤
    • 腦瘤/神經系統腫瘤
    • 軟組織 (心臟之外)的癌症
    • 骨腫瘤、關節腫瘤
    • 眼腫瘤、眼窩肉瘤

外部照射療法市場

  • 簡介
    • 外部照射療法
      • 治療設備的各類型
        • 鈷60照射設備
        • 線性加速器
        • 質子治療設備
  • 市場概要
  • 市場分析與預測
    • 外部照射療法設備:整體市場規模
      • 線性加速器市場
      • 質子治療設備市場
    • 外部照射療法設備的維修:市場收益額
      • 線性加速器
      • 質子治療設備
  • 推動及阻礙市場要素
    • 線性加速器市場
      • 推動市場要素
      • 阻礙市場要素
    • 質子治療設備
  • 競爭分析
    • 線性加速器市場
    • 質子治療設備市場

內部照射療法市場

  • 簡介
    • 體內照射療法
      • 輻射各方法
        • 恆常照射
        • 一時照射
    • 線量率
      • 低劑量率 (LDR)
      • 中線量率 (MDR)
      • 高線量率 (HDR)
      • 脈衝給藥方式 (PDR)
    • 放射線來源的各類型
      • 適合LDR
      • 適合HDR
    • 後荷裝置
  • 市場概要
  • 市場分析與預測
    • HDR近距離放射治療市場
      • 後荷裝置市場
      • 後荷裝置、服務市場
    • LDR近距離放射治療市場
      • LDR用Seed市場
        • 銫131
        • 鈀103
        • 碘125
      • LDR用針頭市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 競爭分析

簡稱一覽

圖表一覽

目錄
Product Code: iDATA_USIERAD16_RPT

Radiation therapy (RT) is a type of treatment most commonly used against cancer or to control and kill malignant cells. Typically, X-rays, gamma rays or charged particles (CPs) are the medium used. For oncological applications, RT works by attacking a cancerous cell's DNA.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY FOR COMPLETE REPORT SUITE

  • 1.1. MARKET OVERVIEW
  • 1.2. COMPETITIVE LANDSCAPE
  • 1.3. MARKET TRENDS
  • 1.4. KEY MARKET DEVELOPMENTS
  • 1.5. INCIDENCE RATES INCLUDED
  • 1.6. PROCEDURE NUMBERS
  • 1.7. MARKETS INCLUDED
  • 1.8. KEY REPORT UPDATES
  • 1.9. VERSION HISTORY

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

CANCER INCIDENCE RATES

  • 3.1. INTRODUCTION
  • 3.2. CANCER BY TYPE
    • 3.2.1. Genital Cancer
    • 3.2.2. Digestive Cancer
    • 3.2.3. Respiratory Cancer
    • 3.2.4. Breast Cancer
    • 3.2.5. Urinary Cancer
    • 3.2.6. Skin Cancer
    • 3.2.7. Lymphoma
    • 3.2.8. Endocrine System Cancer
    • 3.2.9. Leukemia
    • 3.2.10. Oral Cavity/Larynx
    • 3.2.11. Myeloma
    • 3.2.12. Brain/Other Nervous System
    • 3.2.13. Soft Tissue (Non-Heart)
    • 3.2.14. Bones and Joints
    • 3.2.15. Eye and Orbit

EXTERNAL RADIATION THERAPY MARKET

  • 4.1. INTRODUCTION
    • 4.1.1. External Radiation
      • 4.1.1.1. External Radiation Therapy Device Types
        • 4.1.1.1.1. Cobalt-60 Machines
        • 4.1.1.1.2. Linear Particle Accelerators
        • 4.1.1.1.3. Proton Therapy Machines
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Total External Radiation Therapy Device Market
      • 4.3.1.1. Linear Accelerator Device Market
      • 4.3.1.2. Proton Therapy Device Market
    • 4.3.2. Total External Radiation Therapy Device Maintenance Revenue
      • 4.3.2.1. Linear Accelerator Maintenance Revenue
      • 4.3.2.2. Proton Therapy Device Maintenance Revenue
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Linear Accelerator Device Market
      • 4.4.1.1. Market Drivers
      • 4.4.1.2. Market Limiters
    • 4.4.2. Proton Therapy Device Market
      • 4.4.2.1. Market Drivers
      • 4.4.2.2. Market Limiters
  • 4.5. COMPETITIVE ANALYSIS
    • 4.5.1. Linear Accelerator Device Market
    • 4.5.2. Proton Therapy Device Market

INTERNAL RADIATION THERAPY DEVICE MARKET

  • 5.1. INTRODUCTION
    • 5.1.1. Internal Radiation
      • 5.1.1.1. Types of Internal Radiation Therapy
        • 5.1.1.1.1. Permanent Rti
        • 5.1.1.1.2. Temporary Rti
      • 5.1.1.2. Dose Rate
        • 5.1.1.2.1. Low-Dose Rate (LDR)
        • 5.1.1.2.2. Medium-Dose Rate (MDR)
        • 5.1.1.2.3. High-Dose Rate (HDR)
        • 5.1.1.2.4. Pulsed-Dose Rate (PDR)
      • 5.1.1.3. Types of Internal Radiation Therapy Sources
        • 5.1.1.3.1. LDR Sources
        • 5.1.1.3.2. HDR Sources
        • 5.1.1.4. Afterloaders
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total HDR Brachytherapy Market
      • 5.3.1.1. Afterloader Market
      • 5.3.1.2. Afterloader Service Market
    • 5.3.2. Total LDR Brachytherapy Market
      • 5.3.2.1. Total LDR Seed Market
        • 5.3.2.1.1. Total Cesium-131 Seed Market
        • 5.3.2.1.2. Total Paladium-103 Seed Market
        • 5.3.2.1.3. Total Iodine-125 Seed Market
      • 5.3.2.2. LDR Needle Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1-1: Interventional Oncology Device Market by Segment, U.S., 2012-2022 (US$M)
  • Chart 1-2: Interventional Oncology Device Market Overview, U.S., 2015 & 2022
  • Chart 3-1: Male Incidence, Genital Cancer, U.S., 2014
  • Chart 3-2: Male Deaths, Genital Cancer, U.S., 2014
  • Chart 3-3: Female Incidence, Genital Cancer, U.S., 2014
  • Chart 3-4: Female Deaths, Genital Cancer, U.S., 2014
  • Chart 3-5: Male Incidence, Digestive Cancer, U.S., 2014
  • Chart 3-6: Male Deaths, Digestive Cancer, U.S., 2014
  • Chart 3-7: Female Incidence, Digestive Cancer, U.S., 2014
  • Chart 3-8: Female Deaths, Digestive Cancer, U.S., 2014
  • Chart 3-9: Male Incidence, Respiratory Cancer, U.S., 2014
  • Chart 3-10: Male Deaths, Respiratory Cancer, U.S., 2014
  • Chart 3-11: Female Incidence, Respiratory Cancer, U.S., 2014
  • Chart 3-12: Female Deaths, Respiratory Cancer, U.S., 2014
  • Chart 3-13: Incidence by Gender, Breast Cancer, U.S., 2014
  • Chart 3-14: Deaths by Gender, Breast Cancer, U.S., 2014
  • Chart 3-15: Male Incidence, Urinary Cancer, U.S., 2014
  • Chart 3-16: Male Deaths, Urinary Cancer, U.S., 2014
  • Chart 3-17: Female Incidence, Urinary Cancer, U.S., 2014
  • Chart 3-18: Female Deaths, Urinary Cancer, U.S., 2014
  • Chart 3-19: Male Incidence, Skin Cancer, U.S., 2014
  • Chart 3-20: Male Deaths, Skin Cancer, U.S., 2014
  • Chart 3-21: Female Incidence, Skin Cancer, U.S., 2014
  • Chart 3-22: Female Deaths, Skin Cancer, U.S., 2014
  • Chart 3-23: Male Incidence, Lymphoma Cancer, U.S., 2014
  • Chart 3-24: Male Deaths, Lymphoma Cancer, U.S., 2014
  • Chart 3-25: Female Incidence, Lymphoma Cancer, U.S., 2014
  • Chart 3-26: Female Deaths, Lymphoma Cancer, U.S., 2014
  • Chart 3-27: Male Incidence, Endocrine Cancer, U.S., 2014
  • Chart 3-28: Male Deaths, Endocrine Cancer, U.S., 2014
  • Chart 3-29: Female Incidence, Endocrine Cancer, U.S., 2014
  • Chart 3-30: Female Deaths, Endocrine Cancer, U.S., 2014
  • Chart 3-31: Male Incidence, Leukemia Cancer, U.S., 2014
  • Chart 3-32: Male Deaths, Leukemia Cancer, U.S., 2014
  • Chart 3-33: Female Incidence, Leukemia Cancer, U.S., 2014
  • Chart 3-34: Female Deaths, Leukemia Cancer, U.S., 2014
  • Chart 3-35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 3-39: Incidence by Gender, Myeloma Cancer, U.S., 2014
  • Chart 3-40: Deaths by Gender, Myeloma Cancer, U.S., 2014
  • Chart 3-41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2014
  • Chart 3-42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2014
  • Chart 3-43: Incidence by Gender, Soft Tissue Cancer, U.S., 2014
  • Chart 3-44: Deaths by Gender, Soft Tissue Cancer, U.S., 2014
  • Chart 3-45: Incidence by Gender, Bone and Joint Cancers, U.S., 2014
  • Chart 3-46: Deaths by Gender, Bone and Joint Cancers, U.S., 2014
  • Chart 3-47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2014
  • Chart 3-48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2014
  • Chart 4-1: External Radiation Therapy Market by Segment, U.S., 2012-2022
  • Chart 4-2: External Radiation Therapy Market Breakdown, U.S., 2015
  • Chart 4-3: External Radiation Therapy Market Breakdown, U.S., 2022
  • Chart 4-4: Total External Radiation Therapy Device Market by Segment, U.S., 2012-2022
  • Chart 4-5: Linear Accelerator Device Market, U.S., 2012-2022
  • Chart 4-6: Proton Therapy Device Market, U.S., 2012-2022
  • Chart 4-7: Total External Radiation Therapy Device Maintenance Revenue by Segment, U.S., 2012-2022
  • Chart 4-8: Linear Accelerator Maintenance Revenue, U.S., 2012-2022
  • Chart 4-9: Proton Therapy Device Maintenance Revenue, U.S., 2012-2022
  • Chart 4-10: Leading Competitors, Linear Accelerator Device Market, U.S., 2015
  • Chart 4-11: Leading Competitors by Installed Base, Proton Therapy Device Market, U.S., 2015
  • Chart 5-1: Internal Radiation Therapy Device Market by Segment, U.S., 2012-2022
  • Chart 5-2: Internal Radiation Therapy Device Market Breakdown, U.S., 2015
  • Chart 5-3: Internal Radiation Therapy Device Market, U.S., 2022
  • Chart 5-4: Total HDR Brachytherapy Market by Segment, U.S., 2012-2022
  • Chart 5-5: Afterloader Market, U.S., 2012-2022
  • Chart 5-6: Afterloader Service Market, U.S., 2012-2022
  • Chart 5-7: Total LDR Brachytherapy Market by Segment, U.S., 2012-2022
  • Chart 5-8: Total LDR Seed Market, U.S., 2012-2022
  • Chart 5-9: Total LDR Seed Market by Segment, U.S., 2012-2022
  • Chart 5-10: Total Cesium-131 Seed Market by Segment, U.S., 2012-2022
  • Chart 5-11: Stranded Cesium-131 Seed Market, U.S., 2012-2022
  • Chart 5-12: Non-Stranded Cesium-131 Seed Market, U.S., 2012-2022
  • Chart 5-13: Total Paladium-103 Seed Market by Segment, U.S., 2012-2022
  • Chart 5-14: Stranded Paladium-103 Seed Market, U.S., 2012-2022
  • Chart 5-15: Non-Stranded Paladium-103 Seed Market, U.S., 2012-2022
  • Chart 5-16: Total Iodine-125 Seed Market by Segment, U.S., 2012-2022
  • Chart 5-17: Stranded Iodine-125 Seed Market, U.S., 2012-2022
  • Chart 5-18: Non-Stranded Iodine-125 Seed Market, U.S., 2012-2022
  • Chart 5-19: LDR Needle Market, U.S., 2012-2022
  • Chart 5-20: Leading Competitors, Internal Radiation Therapy Device Market, U.S., 2015

LIST OF FIGURES

  • Figure 1-1: Interventional Oncology Device Market Share Ranking by Segment, U.S., 2015
  • Figure 1-2: Companies Research in this Report Suite, U.S., 2015
  • Figure 1-3: Factors Impacting the Interventional Oncology Device Market by Segment, U.S.
  • Figure 1-4: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (1 of 3)
  • Figure 1-5: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (2 of 3)
  • Figure 1-6: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (3 of 3)
  • Figure 1-7: Cancer Incidence Rates Covered, U.S., 2015 (1 of 2)
  • Figure 1-8: Cancer Incidence Rates Covered, U.S., 2015 (2 of 2)
  • Figure 1-9: Interventional Oncology Procedures Covered, U.S., 2015
  • Figure 1-10: Procedural Codes, U.S., 2015
  • Figure 1-11: Interventional Oncology Device Markets Covered, U.S., 2012-2022 (1 of 2)
  • Figure 1-12: Interventional Oncology Device Markets Covered, U.S., 2012-2022 (2 of 2)
  • Figure 1-13: Key Report Updates, U.S., 2016
  • Figure 1-14: Version History
  • Figure 3-1: Genital Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-2: Digestive Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-3: Respiratory Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-4: Breast Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-5: Urinary Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-6: Skin Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-8: Endocrine Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-9: Leukemia Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-11: Myeloma Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-13: Soft Tissue (Non-Heart) Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 3-15: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-1: External Radiation Therapy Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-2: Total External Radiation Therapy Device Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-3: Linear Accelerator Device Market, U.S., 2012-2022
  • Figure 4-4: Proton Therapy Device Market, U.S., 2012-2022
  • Figure 4-5: Total External Radiation Therapy Device Maintenance Revenue by Segment, U.S., 2012-2022 (US$M)
  • Figure 4-6: Linear Accelerator Maintenance Revenue, U.S., 2012-2022
  • Figure 4-7: Proton Therapy Device Maintenance Revenue, U.S., 2012-2022
  • Figure 4-8: Drivers and Limiters, Linear Accelerator Device Market, U.S., 2015
  • Figure 4-9: Drivers and Limiters, Proton Therapy Device Market, U.S., 2015
  • Figure 4-10: Leading Competitors, Linear Accelerator Device Market, U.S., 2015
  • Figure 4-11: Leading Competitors by Installed Base, Proton Therapy Device Market, U.S., 2015
  • Figure 5-1: Internal Radiation Therapy Device Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 5-2: Total HDR Brachytherapy Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 5-3: Afterloader Market, U.S., 2012-2022
  • Figure 5-4: Afterloader Service Market, U.S., 2012-2022
  • Figure 5-5: Total LDR Brachytherapy Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 5-6: Total LDR Seed Market, U.S., 2012-2022
  • Figure 5-7: Total LDR Seed Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 5-8: Total Cesium-131 Seed Market by Segment, U.S., 2012-2022
  • Figure 5-9: Stranded Cesium-131 Seed Market, U.S., 2012-2022
  • Figure 5-10: Non-Stranded Cesium-131 Seed Market, U.S., 2012-2022
  • Figure 5-11: Total Paladium-103 Seed Market by Segment, U.S., 2012-2022
  • Figure 5-12: Stranded Paladium-103 Seed Market, U.S., 2012-2022
  • Figure 5-13: Non-Stranded Paladium-103 Seed Market, U.S., 2012-2022
  • Figure 5-14: Total Iodine-125 Seed Market by Segment, U.S., 2012-2022
  • Figure 5-15: Stranded Iodine-125 Seed Market, U.S., 2012-2022
  • Figure 5-16: Non-Stranded Iodine-125 Seed Market, U.S., 2012-2022
  • Figure 5-17: LDR Needle Market, U.S., 2012-2022
  • Figure 5-18: Drivers and Limiters, Internal Radiation Therapy Device Market, U.S., 2015
  • Figure 5-19: Leading Competitors, Internal Radiation Therapy Device Market, U.S., 2015
Back to Top